Neurocrine Biosciences (NBIX) Change in Inventory (2017 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Change in Inventory of $6.5 million for Q2 2026, up 409.52% year-over-year from $1.3 million in Q2 2025, and up 251.16% on a QoQ basis from -$4.3 million in Q1 2026.
Neurocrine Biosciences (NBIX) Change in Inventory (2017 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Change in Inventory for 10 years, with the latest figure at $6.5 million in Q2 2026.
- Change in Inventory for Q2 2026 came in at $6.5 million, up 409.52% year-over-year; the trailing twelve-month figure through Jun 2026 was $17.9 million (up 23.45% YoY), and the FY2025 annual result was $15.3 million, down 19.9% from the prior year.
- Change in Inventory improved to $6.5 million in Q2 2026, from -$4.3 million in the prior quarter.
- Over five years, Change in Inventory peaked at $12.3 million in Q3 2025 and troughed at -$4.3 million in Q1 2026.
- A 5-year average of $1.9 million and a median of $600000.0 in 2022 frame the typical range for Change in Inventory.
- The widest annual swing landed in 2023, when Change in Inventory tumbled 633.33%; it then jumped 1188.89% in 2024.
- A 5-year view of Change in Inventory shows it stood at -$3.9 million in 2022, then soared by 123.08% to $900000.0 in 2023, then jumped by 1188.89% to $11.6 million in 2024, then plunged by 70.69% to $3.4 million in 2025, then soared by 91.18% to $6.5 million in 2026.
- Per Business Quant data, the three most recent Change in Inventory figures were $6.5 million in Q2 2026, -$4.3 million in Q1 2026, and $3.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | -7.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.50 Mn |
| Jun 30, 2026 | 6.50 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Mar 31, 2026 | -4.30 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Dec 31, 2025 | 3.40 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Sep 30, 2025 | 12.30 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Jun 30, 2025 | -2.10 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | 11.60 Mn |
| Dec 31, 2024 | 11.60 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | -1.10 Mn |
| Mar 31, 2024 | -1.10 Mn |